150 related articles for article (PubMed ID: 11366229)
1. FDA news. Food and Drug Administration.
Res Initiat Treat Action; 1999 Jan; 5(1):20. PubMed ID: 11366229
[TBL] [Abstract][Full Text] [Related]
2. Kaposi's sarcoma: new topical treatment approved.
James JS
AIDS Treat News; 1999 Feb; (No 313):1. PubMed ID: 11366235
[TBL] [Abstract][Full Text] [Related]
3. Viramune (Nevirapine) is approved for children.
Vazquez E
Posit Aware; 1998; 9(6):17. PubMed ID: 11366470
[TBL] [Abstract][Full Text] [Related]
4. FDA approves DaunoXome as first-line therapy for Kaposi's sarcoma. Food and Drug Administration.
J Int Assoc Physicians AIDS Care; 1996 May; 2(5):50-1. PubMed ID: 11363534
[TBL] [Abstract][Full Text] [Related]
5. Kaposi's sarcoma regression following treatment with a triple antiretroviral regimen containing nevirapine.
Shaw AJ; McLean KA
Int J STD AIDS; 1999 Jun; 10(6):417-8. PubMed ID: 10414887
[No Abstract] [Full Text] [Related]
6. FDA notifications. FDA approves label change for nevirapine.
AIDS Alert; 2008 Aug; 23(8):91-2. PubMed ID: 18724490
[No Abstract] [Full Text] [Related]
7. FDA notifications. Tentative approval granted of generic nevirapine.
AIDS Alert; 2007 Sep; 22(9):104-5. PubMed ID: 18415956
[No Abstract] [Full Text] [Related]
8. Clearance given for Panretin gel.
Oncologist; 1999; 4(2):187. PubMed ID: 10337390
[No Abstract] [Full Text] [Related]
9. HIV drug now approved for use with protease inhibitors.
Nurse Pract; 1998 Oct; 23(10):89. PubMed ID: 9805335
[No Abstract] [Full Text] [Related]
10. Nevirapine is now available for use in HIV-infected children.
Fac Notes (New Orleans La); 1999; 11(2):11. PubMed ID: 11810878
[No Abstract] [Full Text] [Related]
11. FDA advisory on nevirapine.
AIDS Treat News; 2005 Jan; (409):7. PubMed ID: 15791716
[TBL] [Abstract][Full Text] [Related]
12. KS drug goes to FDA. Food and Drug Administration.
GMHC Treat Issues; 1998 May; 12(5):7. PubMed ID: 11365479
[TBL] [Abstract][Full Text] [Related]
13. FDA notifications. FDA gives tentative approval for stavudine, lamivudine & nevirapine tablet.
AIDS Alert; 2009 Sep; 24(9):105-6. PubMed ID: 19938312
[No Abstract] [Full Text] [Related]
14. FDA notifications. Zidovudine approved for pediatric use.
AIDS Alert; 2009 Sep; 24(9):105. PubMed ID: 19928325
[No Abstract] [Full Text] [Related]
15. Delavirdine (Rescriptor) approved.
James JS
AIDS Treat News; 1997 Apr; (No 269):1-3. PubMed ID: 11364252
[TBL] [Abstract][Full Text] [Related]
16. FDA approves first new class of HIV drugs. Food and Drug Administration.
AIDS Alert; 1996 Aug; 11(8):89. PubMed ID: 11363655
[TBL] [Abstract][Full Text] [Related]
17. FDA looks at full approval for d4T. Food and Drug Administration.
Posit Aware; 1996; 7(1):7. PubMed ID: 11363131
[TBL] [Abstract][Full Text] [Related]
18. FDA notifications. Lamivudine/zidovudine combination approved for pediatric use.
AIDS Alert; 2009 Sep; 24(9):105. PubMed ID: 19938311
[No Abstract] [Full Text] [Related]
19. FDA notifications. Tentative approval for generic nevirapine tablets.
AIDS Alert; 2007 Oct; 22(10):118-9. PubMed ID: 18418905
[No Abstract] [Full Text] [Related]
20. FDA notifications. FDA approved pediatric efficacy supplement for Retrovir syrup.
AIDS Alert; 2008 Nov; 23(11):128. PubMed ID: 19043870
[No Abstract] [Full Text] [Related]
[Next] [New Search]
